Mohammad Amjad Kamal
Mohammad Amjad Kamal
研究生物化学，神经科学，代谢组学，纳米抗癌药物，人工淋巴引流和miRNA。领导其研究团队（全球100多名科学家）研究神经退行性疾病，如阿尔茨海默氏症和帕金森病，出版数超过500。参与多项美国国立卫生研究院，国立衰老研究所，神经内科学实验室，细胞内研究计划项目。
Studying biochemistry, neuroscience, metabolomics, nano anti-cancer drugs, artificial lymphatic drainage, and miRNA. Leading a research team (comprising over 100 scientists worldwide) investigating neurodegenerative diseases such as Alzheimer's and Parkinson's, with over 500 publications. Involved in multiple projects funded by the National Institutes of Health, the National Institute on Aging, the Neurology Laboratory, and the Cellular Research Program.